Study casts doubt on long-term bisphosphonate efficacy
More is not necessarily better in preventing hip fracture, researchers say
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/hipfracture_dreamstime_s_109039865_nov2019_-5.jpg)
Long-term oral bisphosphonate therapy doesn’t seem to give women any extra protection against osteoporotic hip fracture, a new study suggests.
But there’s a hint that staying on the therapy for seven years could be the sweet spot that might spare some women from the morbidity associated with longer term use.